Wyeth's 'Medical Ghostwriting' Docs To See Daylight

Law360, New York (July 27, 2009, 2:36 PM EDT) -- The judge in charge of the multidistrict litigation over Wyeth Pharmaceuticals Inc.'s drug Prempro has unsealed discovery pertaining to "medical ghostwriting," granting a bid from a medical journal seeking to expose drugmakers that pay for journal articles.

On Friday, Judge William R. Wilson of the U.S. District Court for the Eastern District of Arkansas ordered that materials related to “ghostwriting” be de-designated as confidential as of June 30.

Medical journal PLOS Medicine had moved for access to discovery materials involving ghostwriting practices. PLOS Medicine contends the...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

In Re: Prempro Products et al


Case Number

4:03-cv-01507

Court

Arkansas Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Billy Roy Wilson

Date Filed

March 7, 2003

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.